|
Oct 26
|
Dynavax to Report Third Quarter 2023 Financial Results and Host Conference Call on November 2, 2023
|
|
Oct 26
|
Alkermes (ALKS) Down Despite Q3 Earnings & Revenue Beat
|
|
Oct 26
|
Dynavax Technologies (DVAX) Expected to Beat Earnings Estimates: Should You Buy?
|
|
Oct 24
|
Dynavax (DVAX) to Report Q3 Earnings: Will It Beat Estimates?
|
|
Sep 12
|
Aquestive's (AQST) Libervant Accepted for FDA Review, Stock Up
|
|
Sep 12
|
Bicycle (BCYC) to Begin Pivotal Bladder Cancer Study, Stock Up
|
|
Sep 11
|
J&J (JNJ) Seeks Approval for Bladder Cancer Drug in Europe
|
|
Sep 11
|
Codexis (CDXS) Transfers Leasing Rights to Vaxcyte, Stock Up
|
|
Sep 8
|
Merck's (MRK) Ebola Vaccine Gets Approval for Kids in Europe
|
|
Sep 7
|
J&J (JNJ) to End Pulmonary Hypertension Study on Opsumit
|
|
Sep 6
|
Dynavax to Present at the H.C. Wainwright 25th Annual Global Investment Conference
|
|
Sep 6
|
AstraZeneca (AZN) Gets FDA CRL for Ultomiris in New Indication
|
|
Aug 11
|
Insider Sell: President & COO David Novack Sells 40,000 Shares of Dynavax Technologies Corp ...
|
|
Aug 10
|
Jazz (JAZZ) Beats on Q2 Earnings & Sales, Raises '23 View
|
|
Aug 10
|
Wall Street Analysts See a 70.61% Upside in Dynavax Technologies (DVAX): Can the Stock Really Move This High?
|
|
Aug 7
|
Dynavax Technologies Stock Sees Renewed Technical Strength
|
|
Aug 6
|
Getting Another Shot of Biotech Dynavax Technologies
|
|
Apr 9
|
Dynavax Technologies (NASDAQ:DVAX) delivers shareholders solid 53% CAGR over 3 years, surging 6.4% in the last week alone
|